Enabling Late-Stage Success In Drug Product Development | CPHI Worldwide Milan

Transitioning a drug product from early-stage feasibility to commercial readiness requires a critical shift toward robustness, scalability, and strict regulatory compliance. Ensuring seamless manufacturing tech transfers and mitigating process-related risks are essential steps to avoid costly late-stage delays.

Optimizing liquid and lyophilized formulations for manufacturability, conducting rigorous stability studies, and generating comprehensive CMC data packages establish a reliable path to market. Collaborating with specialized development partners helps de-risk the commercial scale-up process, ensuring product quality remains consistent at volume.

Explore how integrated formulation expertise and analytical characterization bridge the gap between development and commercial manufacturing requirements. Review the full overview of late-stage solutions and request a meeting with experts to secure a predictable path toward a successful commercial launch.